Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related adverse reactions in the nervous system

Immune checkpoint inhibitors (ICIs) can cause adverse reactions in the nervous system. The incidence rate is 0.1%–12% and 80% of nervous system adverse reactions occur within the first four months of application. ICIs can cause diseases of various parts of the nervous system including central nervou...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jiayu, Niu, Jingwen, Shen, Dongchao, Liu, Mingsheng, Tan, Ying, Li, Yi, huang, Yangyu, Cui, Liying, Guan, Yuzhou, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Clinical Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996972/
https://www.ncbi.nlm.nih.gov/pubmed/31823509
http://dx.doi.org/10.1111/1759-7714.13266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996972/
https://www.ncbi.nlm.nih.gov/pubmed/31823509
http://dx.doi.org/10.1111/1759-7714.13266

Ejemplares similares